Drug name - Solodyn
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8722650 | BAUSCH | Extended-release minocycline dosage forms |
Jun, 2025
(2 years from now) | |
| US8252776 | BAUSCH | Minocycline oral dosage forms for the treatment of acne |
Jun, 2025
(2 years from now) | |
| US8268804 | BAUSCH | Minocycline oral dosage forms for the treatment of acne |
Jun, 2025
(2 years from now) | |
| US7790705 | BAUSCH | Minocycline oral dosage forms for the treatment of acne |
Jun, 2025
(2 years from now) | |
| US7919483 | BAUSCH | Method for the treatment of acne |
Mar, 2027
(4 years from now) | |
| US7544373 | BAUSCH | Minocycline oral dosage forms for the treatment of acne |
Apr, 2027
(4 years from now) | |
| US7541347 | BAUSCH | Minocycline oral dosage forms for the treatment of acne |
Apr, 2027
(4 years from now) | |
| US9192615 | BAUSCH | Method for the treatment of acne and certain dosage forms thereof |
Nov, 2031
(9 years from now) | |
Drugs and Companies using MINOCYCLINE HYDROCHLORIDE ingredient
Treatment: Treatment of acne; Treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris
Dosage: TABLET, EXTENDED RELEASE;ORAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| EQ 45MG BASE | TABLET, EXTENDED RELEASE;ORAL | Discontinued |
| EQ 55MG BASE | TABLET, EXTENDED RELEASE;ORAL | Prescription |
| EQ 65MG BASE | TABLET, EXTENDED RELEASE;ORAL | Prescription |
| EQ 80MG BASE | TABLET, EXTENDED RELEASE;ORAL | Prescription |
| EQ 90MG BASE | TABLET, EXTENDED RELEASE;ORAL | Discontinued |
| EQ 105MG BASE | TABLET, EXTENDED RELEASE;ORAL | Prescription |
| EQ 115MG BASE | TABLET, EXTENDED RELEASE;ORAL | Prescription |
| EQ 135MG BASE | TABLET, EXTENDED RELEASE;ORAL | Discontinued |
availability in other generic markets.
Click on the highlighted region to filter.